30 a.m. Eastern Time Monday, April 11 to Discuss Phase 3 Trial Results for Dimebon in Huntington Disease

Show Health and Fitness Publications

Mon, April 18, 2011

[ Mon, Apr 18th 2011 ]: Market Wire

CytRx Announces the Publication of a Peer-Reviewe .. mibarotenea?s Successful Elimination of Recurrent

[ Mon, Apr 18th 2011 ]: Market Wire

Young Biotech Firms Seek Long Term Relevance

[ Mon, Apr 18th 2011 ]: Market Wire

BioSante Pharmaceuticals Announces Pancreatic and Prostate Cancer Vaccine License

[ Mon, Apr 18th 2011 ]: Market Wire

CHMP beveelt uitbreiding TYSABRI-bijsluiter aan m .. or anti-JC virus als derde factor om risico PML v

[ Mon, Apr 18th 2011 ]: Market Wire

CHMP recomienda actualizar la etiqueta de TYSABRI .. ti-JCV como tercer factor para estratificar los r

[ Mon, Apr 18th 2011 ]: Market Wire

[ Mon, Apr 18th 2011 ]: Market Wire

Community Health Systems to Release 1Q Earnings o .. April 28 to Discuss Financial Results and Address

[ Mon, Apr 18th 2011 ]: Market Wire

Prism Medical Announces Acquisition of Movement 2 Ltd.

[ Mon, Apr 18th 2011 ]: Market Wire

PROTOX ANNOUNCES MOVE TO SAN DIEGO AND SENIOR MANAGEMENT TRANSITION

[ Mon, Apr 18th 2011 ]: Market Wire

BioClinica to Release First Quarter 2011 Financial Results on May 4, 2011

[ Mon, Apr 18th 2011 ]: Market Wire

Le Comit© des m©dicaments usage humain (CHMP) r .. ©tiquetage de TYSABRI afin d'inclure le statut d

[ Mon, Apr 18th 2011 ]: Market Wire

CHMP empfiehlt Aktualisierung der Produktinformat .. me des JC-Virus-Antikrperstatus als dritten Fakto

[ Mon, Apr 18th 2011 ]: Market Wire

CML HealthCare Inc. Declares April Dividend

[ Mon, Apr 18th 2011 ]: Market Wire

CHMP raccomanda l'aggiornamento dell'etichetta de .. s di anticorpo anti virus JC come terzo fattore p

Sun, April 17, 2011

[ Sun, Apr 17th 2011 ]: Market Wire

Helix BioPharma Corp. to Participate in Upcoming .. n New York Focused on Women's Health and Wellness

[ Sun, Apr 17th 2011 ]: Market Wire

CHMP Recommends Updating TYSABRI Labeling with an .. as a Third Factor to Further Stratify Risk of PML

[ Sun, Apr 17th 2011 ]: Market Wire

D. Medical Enters US$10 Million Standby Equity Agreement

Fri, April 15, 2011

[ Fri, Apr 15th 2011 ]: Market Wire

ARCA biopharma Licenses Exclusive Worldwide Rights to Bucindolol Genetic Markers

[ Fri, Apr 15th 2011 ]: Market Wire

Aethlon Medical Discloses Interview on Therapeutic Strategies to Address Hepatitis C (HCV) and HIV

[ Fri, Apr 15th 2011 ]: Market Wire

Health Management Associates, Inc. Announces Firs .. Quarter 2011 Earnings Conference Call and Webcast

[ Fri, Apr 15th 2011 ]: Market Wire

The Law Offices of Vincent Wong Announce an Inves .. es of Fiduciary Duty by the Board of American Med

[ Fri, Apr 15th 2011 ]: Market Wire

Amedisys to Present at the 15th Annual Burkenroad Reports Investment Conference

[ Fri, Apr 15th 2011 ]: Market Wire

Merck Commences Tender Offer for all Outstanding Shares of Inspire Pharmaceuticals, Inc.

[ Fri, Apr 15th 2011 ]: Market Wire

Vertex Announces the Date of its First Quarter 2011 Financial Results Conference Call and Webcast

[ Fri, Apr 15th 2011 ]: Market Wire

Preliminary Injunction Ordered in POZEN Treximet Patent Litigation

[ Fri, Apr 15th 2011 ]: Market Wire

ImmunoCellular Therapeuticsa? Cancer Vaccine: Saf .. Results for Glioblastoma Trial Presented at Ameri

[ Fri, Apr 15th 2011 ]: Market Wire

Bydureona" Recommended for Approval in Europe

[ Fri, Apr 15th 2011 ]: Market Wire

Merck Reaffirms 2011 Non-GAAP EPS Target

[ Fri, Apr 15th 2011 ]: Market Wire

Repligen Announces Conference Call to Discuss Pre .. ancial Results and Fiscal Year 2012 Corporate Goa

[ Fri, Apr 15th 2011 ]: Market Wire

Merck and Johnson & Johnson Reach Agreement on Distribution Rights for REMICADE® and SIMPONI®

Thu, April 14, 2011

[ Thu, Apr 14th 2011 ]: Market Wire

DaVita Hosts Nationwide Celebrations for 35,000 Teammates

[ Thu, Apr 14th 2011 ]: Market Wire

Cubist Pharmaceuticals 1Q11 Total Net Revenues Up .. U.S. Net Revenues for CUBICIN Up 14% to $153.7 Mi

[ Thu, Apr 14th 2011 ]: Market Wire

Impax Laboratories Schedules Conference Call and Webcast for First Quarter 2011 Financial Results

[ Thu, Apr 14th 2011 ]: Market Wire

Synovis Life Technologies Receives 2011 Manufactu .. ear Award from Manufacturers Alliance Association

[ Thu, Apr 14th 2011 ]: Market Wire

Alliance HealthCare Services Announces Profession .. Radiology Services Acquisition of 24/7 Radiology

[ Thu, Apr 14th 2011 ]: Market Wire

Osiris Therapeutics Wins Top Scoring Abstract at the 24th Annual Symposium on Advanced Wound Care

[ Thu, Apr 14th 2011 ]: Market Wire

Tornier Announces Launch of BioFiber® Surgical M .. Tendon Repair at Arthroscopic Surgery Conference

[ Thu, Apr 14th 2011 ]: Market Wire

Geron to Webcast Analyst and Investor Meeting on .. ompanya?s Cell Therapy Programs on April 19, 2011

[ Thu, Apr 14th 2011 ]: Market Wire

InSite Vision Updates Special Protocol Assessment .. or Phase 3 Trial of AzaSite Plusa" and DexaSitea"

[ Thu, Apr 14th 2011 ]: Market Wire

MedMira';s Multiplo Rapid Test to Be Used by Canadian Forces Health Services Group

[ Thu, Apr 14th 2011 ]: Market Wire

St. Jude Medical Announces Approval of ShockGuard .. onTxa" Programming for Unify and Fortify Implanta

[ Thu, Apr 14th 2011 ]: Market Wire

RXi Pharmaceuticals Completes Apthera Acquisition

[ Thu, Apr 14th 2011 ]: Market Wire

Human Genome Sciences Updates Investors on Progress of BENLYSTA® Launch and Future Priorities

[ Thu, Apr 14th 2011 ]: Market Wire

Medisafe 1 Technologies Closes $5 Million Equity Funding Agreement

Wed, April 13, 2011

[ Wed, Apr 13th 2011 ]: Market Wire

Gilead Sciences to Release First Quarter 2011 Financial Results on Wednesday, April 20, 2011

[ Wed, Apr 13th 2011 ]: Market Wire

Covidien Announces DuraSeala" Exact Spine Sealant Receives FDA Approval

[ Wed, Apr 13th 2011 ]: Market Wire

Tenet Healthcare Joins the Obama Administrationa?s Partnership for Patients

[ Wed, Apr 13th 2011 ]: Market Wire

Humana Military and Military Warriors Support Fou .. ll, and Injured Service Members at 2011 Valero Te

[ Wed, Apr 13th 2011 ]: Market Wire

Magellan Health Services Releases 2010 Annual Report

[ Wed, Apr 13th 2011 ]: Market Wire

Orthovita Launches the Aliquot Directional Bone Tamp

[ Wed, Apr 13th 2011 ]: Market Wire

Stellar Pharmaceuticals Inc. and Watson Pharmaceu .. minate Uracyst(R) Supply and Licensing Agreements

[ Wed, Apr 13th 2011 ]: Market Wire

New Corporate Strategy; Ball Named Interim Chairman; Revenue Projections

[ Wed, Apr 13th 2011 ]: Market Wire

Volatility Persists for Xoma and Aastrom Biosciences

[ Wed, Apr 13th 2011 ]: Market Wire

Unigene Increases Support for Tarsa in Preparation for Oral Calcitonin NDA Submission

[ Wed, Apr 13th 2011 ]: Market Wire

Amunix Signs Research Collaboration With Biogen I .. ext Generation Long-Lasting Blood Factor Products

[ Wed, Apr 13th 2011 ]: Market Wire

BioSante Pharmaceuticals Announces Teva New Drug Application for Bio-T-Gela"

[ Wed, Apr 13th 2011 ]: Market Wire

Implant Sciences Announces Explosives Trace Detection Pioneer Dr. William McGann as Advisor

Tue, April 12, 2011

[ Tue, Apr 12th 2011 ]: Market Wire

Wohl & Fruchter Commences Investigation into Alle .. Medicare Fraud at Community Health Systems, Inc.

[ Tue, Apr 12th 2011 ]: Market Wire

The Law Office of Abe Shainberg Launches an Inves .. es of Fiduciary Duty by the Board of American Med

[ Tue, Apr 12th 2011 ]: Market Wire

Forest Laboratories Announces Successful Completi .. ender Offer for Securities of Clinical Data, Inc.

[ Tue, Apr 12th 2011 ]: Market Wire

Fero Industries Appoints Lopez as Chief Operating Officer

[ Tue, Apr 12th 2011 ]: Market Wire

dermaPACE Pivotal Phase III Clinical Trial Result .. atment to Be Presented at the Symposium on Advanc

[ Tue, Apr 12th 2011 ]: Market Wire

Zynex Prepares for First Clinical Evaluation of Blood Volume Monitor Medical Device

[ Tue, Apr 12th 2011 ]: Market Wire

UnitedHealth Group anuncia la marca principal "Optum" para sus empresas de servicios sanitarios

[ Tue, Apr 12th 2011 ]: Market Wire

Teleflex Announces First Quarter 2011 Conference Call Information

[ Tue, Apr 12th 2011 ]: Market Wire

Skystar Bio-Pharmaceutical Reports Record Fourth Quarter and Fiscal Year 2010 Financial Results

[ Tue, Apr 12th 2011 ]: Market Wire

Das fortgesetzte Engagement von Biogen Idec fr Me .. uf der 63. Jahrestagung der amerikanischen Academ

[ Tue, Apr 12th 2011 ]: Market Wire

AVEO Pharmaceuticals Appoints Henri A. Termeer to its Board of Directors

[ Tue, Apr 12th 2011 ]: Market Wire

Illumina to Announce First Quarter 2011 Financial Results on Tuesday, April 26, 2011

[ Tue, Apr 12th 2011 ]: Market Wire

Merck & Co., Inc., und Sun Pharma grnden Joint Ve .. marktung neuartiger Formulierungen und Kombinatio

Mon, April 11, 2011

[ Mon, Apr 11th 2011 ]: Market Wire

Nasce la joint venture tra Merck & Co., Inc., e S .. a commercializzazione di nuove formulazioni e com

[ Mon, Apr 11th 2011 ]: Market Wire

American Medical Systems Shareholder Investigatio .. rm Concerning Acquisition by Endo Pharmaceuticals

[ Mon, Apr 11th 2011 ]: Market Wire

Prana Secures Key PBT2 Patent in Japan and Completes Core IP Suite

[ Mon, Apr 11th 2011 ]: Market Wire

Kendall Law Group Investigates American Medical Systems Holdings Inc. Acquisition for Shareholders

[ Mon, Apr 11th 2011 ]: Market Wire

Immunovaccine Reports Positive Interim Data from .. -0907 in Patients With Breast, Ovarian and Prosta

[ Mon, Apr 11th 2011 ]: Market Wire

VIVITROL® to be Featured in Data Presentations a .. American Society of Addiction Medicine Conference

[ Mon, Apr 11th 2011 ]: Market Wire

AVI BioPharma Receives Approval of Nonproprietary .. henne Muscular Dystrophy Therapeutic Candidate, A

[ Mon, Apr 11th 2011 ]: Market Wire

D. Medical Issued Drug Delivery Device and Method Patent in Japan

[ Mon, Apr 11th 2011 ]: Market Wire

(OTCBB: RGIN) Has PermaDerm Designated as a Combination Product by the FDA

[ Mon, Apr 11th 2011 ]: Market Wire

Cytokinetics Announces Data From Phase IIa "Evide .. of CK-2017357 in Patients With Amyotrophic Later

[ Mon, Apr 11th 2011 ]: Market Wire

Capital Senior Living Corporation Completes the Spring Meadows Transaction

[ Mon, Apr 11th 2011 ]: Market Wire

Hansen Medical Submits 510(k) Application With U.S. FDA for Vascular Robotic System and Catheter

[ Mon, Apr 11th 2011 ]: Market Wire

TechniScan's Breast Imaging Science Featured at National Ultrasound Conference

Sun, April 10, 2011

[ Sun, Apr 10th 2011 ]: Market Wire

Pieris to Present at BioCentury Future Leaders in the Biotech Industry Conference

Sat, April 9, 2011

[ Sat, Apr 09th 2011 ]: Market Wire

Teva Announces Webcast on Results from Phase III .. RO Study of Oral Laquinimod in Multiple Sclerosis

[ Sat, Apr 09th 2011 ]: Market Wire

MannKind Provides Regulatory Update

Fri, April 8, 2011

[ Fri, Apr 08th 2011 ]: Market Wire

The Law Offices of Vincent Wong Announce an Inves .. es of Fiduciary Duty by the Board of Inspire Phar

[ Fri, Apr 08th 2011 ]: Market Wire

30 a.m. Eastern Time Monday, April 11 to Discuss .. 3 Trial Results for Dimebon in Huntington Disease

[ Fri, Apr 08th 2011 ]: Market Wire

Curis to Present at the 18th Annual Future Leaders inthe Biotech Industry Conference

[ Fri, Apr 08th 2011 ]: Market Wire

Medwell Capital Announces that Mimetogen Pharmace .. Recruitment in Phase II Clinical Trial for Dry E

[ Fri, Apr 08th 2011 ]: Market Wire

AVI BioPharma to Present Company Overview at the .. Future Leaders in the Biotech Industry Conference

[ Fri, Apr 08th 2011 ]: Market Wire

BIOLASE Technology to Raise Approximately $1.80 M .. n From Institutional Investors at $5.60 per Share

[ Fri, Apr 08th 2011 ]: Market Wire

Medgenics Announces Pricing of U.S. Initial Public Offering

[ Fri, Apr 08th 2011 ]: Market Wire

ANAVEX APPOINTS DR. CHRISTOPHER SHACKLETON AS AN ADVISOR

[ Fri, Apr 08th 2011 ]: Market Wire

Renegade Petroleum Ltd. Announces Exercise of Over-Allotment Option

[ Fri, Apr 08th 2011 ]: Market Wire

Cytori to Webcast at the Future Leaders in the Biotech Industry Conference on April 15, 2011

[ Fri, Apr 08th 2011 ]: Market Wire

Skystar to Release Fourth Quarter and Full Fiscal Year 2010 Results on Monday, April 11, 2011

[ Fri, Apr 08th 2011 ]: Market Wire

RXi Pharmaceuticals to Webcast Presentation at Bi .. Future Leaders in the Biotech Industry Conference

Thu, April 7, 2011

[ Thu, Apr 07th 2011 ]: Market Wire

CHINA HEALTH LABS &; DIAGNOSTICS LTD. ANNOUNCES C .. ISCUSS RESULTS OF THE YEAR-END AND FOURTH QUARTER

[ Thu, Apr 07th 2011 ]: Market Wire

Faruqi & Faruqi, LLP Announces Shareholder Invest .. quisition of Inspire Pharmaceuticals, Inc. - ISPH

[ Thu, Apr 07th 2011 ]: Market Wire

Healthways Awarded Contract to Expand National Ch .. gram in France and Francea?s Overseas Territories

[ Thu, Apr 07th 2011 ]: Market Wire

Lakeland Industries, Inc. Reports Fiscal 2011 Fourth Quarter and Full Year Financial Results

[ Thu, Apr 07th 2011 ]: Market Wire

Sentinel Rock Oil Inc. and Sundance Energy Corpor .. tion Announce Filing of Filing Statement on Sedar

[ Thu, Apr 07th 2011 ]: Market Wire

Volunteering Does a Body Good

[ Thu, Apr 07th 2011 ]: Market Wire

Mesa Exploration Acquires Potash Projects

[ Thu, Apr 07th 2011 ]: Market Wire

BELLUS HEALTH ISSUES SHARES IN FINAL PAYMENT FOR THE EXERCISE OF ITS LEASE TERMINATION OPTION

[ Thu, Apr 07th 2011 ]: Market Wire

Apple Inc., Dell Inc., Google Inc., Microsoft Cor .. Pharmaceutical Company, Inc., N I S Holdings Corp

[ Thu, Apr 07th 2011 ]: Market Wire

Research on Eli Lilly & Co. and Abbott Laboratori .. s Look to Cancer, China and the Heart to Fill Pat

[ Thu, Apr 07th 2011 ]: Market Wire

BIOLASE to Adopt Direct and Multi-Distributor Sales Model in Germany

[ Thu, Apr 07th 2011 ]: Market Wire

Lpath Initiates Enrollment of iSONEP Phase 1b/2a Proof-of-Concept Trial

[ Thu, Apr 07th 2011 ]: Market Wire

Marina Biotech Initiates Dosing in the Phase 1b/2a START-FAP Clinical Trial of CEQ508

Wed, April 6, 2011

[ Wed, Apr 06th 2011 ]: Market Wire

Briscoe Law Firm and Powers Taylor LLP Investigat .. nc. for Shareholders Concerning Merck Acquisition

[ Wed, Apr 06th 2011 ]: Market Wire

Viking Systems Expects Record Quarterly Revenues for First Quarter 2011

[ Wed, Apr 06th 2011 ]: Market Wire

American Learning Corporation Announces Proposed Acquisition and Sale of Certain Assets

[ Wed, Apr 06th 2011 ]: Market Wire

DERMAXAR Issues Clarification Statement

[ Wed, Apr 06th 2011 ]: Market Wire

AVI BioPharma Announces Exercise of Underwriters' .. on and Closing of Public Offering of Common Stock

[ Wed, Apr 06th 2011 ]: Market Wire

Eckert & Ziegler Withdraws Offer to Acquire Theragenics

[ Wed, Apr 06th 2011 ]: Market Wire

Assisted Living Concepts, Inc. Schedules First Quarter Financial Results Conference Call

[ Wed, Apr 06th 2011 ]: Market Wire

Citigroup Inc., National Semiconductor Corp., For .. ration, Intel Corporation, Dynatronics Corp., N I

[ Wed, Apr 06th 2011 ]: Market Wire

BIOLASE Announces That It Expects Revenues for First Quarter to Exceed Previous Guidance

[ Wed, Apr 06th 2011 ]: Market Wire

Four AACR Presentations Highlight Broad Therapeut .. f Peregrine's First-in-Class PS-Targeting Platfor

[ Wed, Apr 06th 2011 ]: Market Wire

Schizophrenia Reviewed by NeuroInvestment

[ Wed, Apr 06th 2011 ]: Market Wire

New Smartphone Application Helps Get People Walking

[ Wed, Apr 06th 2011 ]: Market Wire

Health Net Supports Tragedy Assistance Program for Survivorsa? Honor Guard Gala

Tue, April 5, 2011

[ Tue, Apr 05th 2011 ]: Market Wire

BioClinica, Inc. to Participate in Upcoming Indus .. onstrate Global Technologya"Enhanced Capabilities

[ Tue, Apr 05th 2011 ]: Market Wire

ZOLL Honored for Excellence in Customer Satisfaction for Tenth Consecutive Year

[ Tue, Apr 05th 2011 ]: Market Wire

Intellipharmaceutics International Inc. to Presen .. h Brothers 8th Annual Small Cap Equity Conference

[ Tue, Apr 05th 2011 ]: Market Wire

DARA Biosciences, Inc. to Present at Taglich Brothers 8th Annual Small Cap Equity Conference

[ Tue, Apr 05th 2011 ]: Market Wire

Exelixis Announces April 7th Webcast of Presentat .. at the Leerink Swann Cancer Roundtable Conference

[ Tue, Apr 05th 2011 ]: Market Wire

American Medical Systems First Quarter 2011 Earnings Conference Call May 3, 2011

[ Tue, Apr 05th 2011 ]: Market Wire

Kindred Healthcare Acquires Home Health Operations in California

[ Tue, Apr 05th 2011 ]: Market Wire

CTD Holdings, Inc. Reports Record 2010 Sales

[ Tue, Apr 05th 2011 ]: Market Wire

Yellowhead Mining Announces Closing of Bought Dea .. te Placement for Gross Proceeds of CDN$20,488,000

[ Tue, Apr 05th 2011 ]: Market Wire

Export Agreement Signed for Causeway Oil

[ Tue, Apr 05th 2011 ]: Market Wire

Yellowhead Mining Inc. Appoints New Advisors to the Board

[ Tue, Apr 05th 2011 ]: Market Wire

Daxor Announces Publication of Research Article W .. olume Analyzer (BVA-100) Can Distinguish True Ane

[ Tue, Apr 05th 2011 ]: Market Wire

Peregrine's PS-Targeting Antibody Significantly I .. t of Sorafenib in Models of Advanced Liver Cancer

Mon, April 4, 2011

[ Mon, Apr 04th 2011 ]: Market Wire

Cambridge Heart Appoints New Vice President

[ Mon, Apr 04th 2011 ]: Market Wire

REMEDIAL II Trial of PLC's RenalGuard® Demonstra .. es Greater Efficacy than Current Standard of Care

[ Mon, Apr 04th 2011 ]: Market Wire

New International Surgical Products Business Prov .. cing Medline's Evidence-Based Solutions Worldwide

[ Mon, Apr 04th 2011 ]: Market Wire

Noted Oregon Cardiologists Conduct First Study on .. ts Using VentriPoint 3D Heart Analysis Technology

[ Mon, Apr 04th 2011 ]: Market Wire

Rosetta Genomics Reports 2010 Fourth Quarter and Full Year Financial Results

[ Mon, Apr 04th 2011 ]: Market Wire

Implant Sciences Announces Fiscal 2011 Q2 Revenue .. 3,147,000, Up 422% vs. Same Period in Fiscal 2010

[ Mon, Apr 04th 2011 ]: Market Wire

Medisafe 1 Technologies Garners Interest From Mul .. al Medical Supplier Becton, Dickinson and Company

[ Mon, Apr 04th 2011 ]: Market Wire

Salix Reviews the International Liver Congress 20 .. e European Association for the Study of the Liver

[ Mon, Apr 04th 2011 ]: Market Wire

Abiomed Announces Schedule of Events at American College of Cardiology 2011 Scientific Conference

[ Mon, Apr 04th 2011 ]: Market Wire

Abiomed Announces Final PROTECT II Study Results .. ulation at American College of Cardiology 2011 Sc

[ Mon, Apr 04th 2011 ]: Market Wire

ImmunoGen, Inc. Announces First Data for Its IMGN529 Product Candidate for Non-Hodgkina?s Lymphoma

[ Mon, Apr 04th 2011 ]: Market Wire

AngioDynamics Launches the Next Generation DuraMax® Stepped-Tip Chronic Dialysis Catheter

[ Mon, Apr 04th 2011 ]: Market Wire

ImmunoGen, Inc. Announces First Data for its Nove .. erapeutic for Ovarian Cancer and Other Carcinomas

Sun, April 3, 2011

[ Sun, Apr 03rd 2011 ]: Market Wire

Antrim Energy and Partners to Drill East Fyne Well, UK North Sea

[ Sun, Apr 03rd 2011 ]: Market Wire

Sanofi-aventis Successfully Completes Exchange Offer for Genzyme Corporation

[ Sun, Apr 03rd 2011 ]: Market Wire

Economic Analysis Demonstrating Cost Effectiveness of Edwards SAPIEN Valve Presented at ACC

[ Sun, Apr 03rd 2011 ]: Market Wire

Edwards Lifesciences Achieves Primary Endpoint in .. theter Valve Study of High-Risk Surgical Patients

Sat, April 2, 2011

[ Sat, Apr 02nd 2011 ]: Market Wire

Orthofix Appoints Vicente Trelles as Senior Vice .. sident, World Wide Operations and Shared Services

[ Sat, Apr 02nd 2011 ]: Market Wire

Investigational Compound PEG-Interferon Lambda Ac .. with Fewer Flu-Like and Musculoskeletal Symptoms

[ Sat, Apr 02nd 2011 ]: Market Wire

Medtronic Announces FDA Approval of InterStim® Therapy for Bowel Control

[ Sat, Apr 02nd 2011 ]: Market Wire

MEDNAX 2011 First Quarter Conference Call/Webcast Scheduled for Tuesday May 3, 2011

Fri, April 1, 2011

[ Fri, Apr 01st 2011 ]: Market Wire

Quidel to Host 2011 Analyst Day in Boston

[ Fri, Apr 01st 2011 ]: Market Wire

Shoal Point Energy Ltd. Provides 3K39 Well Update

[ Fri, Apr 01st 2011 ]: Market Wire

MedMira Announces Second Quarter Results

[ Fri, Apr 01st 2011 ]: Market Wire

LABOPHARM RECEIVES NOTICE FROM NASDAQ REGARDING MINIMUM MARKET VALUE OF LISTED SECURITIES

[ Fri, Apr 01st 2011 ]: Market Wire

PromiusTM Pharma and Valeant Form Collaboration to Market Cloderm® Cream in the United States

[ Fri, Apr 01st 2011 ]: Market Wire

Data on IPX066 APEX-PD Phase III Study for the Tr .. s Disease to be Presented at the American Academy

[ Fri, Apr 01st 2011 ]: Market Wire

Aethlon Medical Discloses Part II of Emerging Opportunities in Biodefense Interview

[ Fri, Apr 01st 2011 ]: Market Wire

St Eugene Commences 2011 Exploration Program at Tartan Lake Mine Project

[ Fri, Apr 01st 2011 ]: Market Wire

Equity Research on Aetna Inc. and Unitedhealth Gr .. nc. - Health Care Providers Positioned for Growth

[ Fri, Apr 01st 2011 ]: Market Wire

Equity Research on Medtronic Inc. and St. Jude Me .. , Implantable Defibrillators Pumping Up Medical A

[ Fri, Apr 01st 2011 ]: Market Wire

AVI BioPharma Prices $30.0 Million Public Offering of Common Stock

[ Fri, Apr 01st 2011 ]: Market Wire

Liberty Metals & Mining Exercises Participation R .. Million IFC Financing for Further Proceeds of Up

[ Fri, Apr 01st 2011 ]: Market Wire

MEDNAX Announces the Acquisition of Practices in San Antonio, TX and Miami, FL

Thu, March 31, 2011

[ Thu, Mar 31st 2011 ]: Market Wire

Radient Pharmaceuticals Announces Preliminary Results From Its Onko-Sure(R) Clinical Study

[ Thu, Mar 31st 2011 ]: Market Wire

Biogen Idec et Knopp Biosciences annoncent le rec .. ent dans une ©tude mondiale de phase III portant

[ Thu, Mar 31st 2011 ]: Market Wire

PhotoMedex Reports 2010 Fourth Quarter and Full Year Results

[ Thu, Mar 31st 2011 ]: Market Wire

Roche Diagnostics Announces the Appointment of Robert Yates as New Head of Roche Applied Science

[ Thu, Mar 31st 2011 ]: Market Wire

MEDIA ADVISORY - Oncolytics Biotech® Inc. to .. sent at 10th Annual Needham Healthcare Conference

[ Thu, Mar 31st 2011 ]: Market Wire

Apthera and RXi Pharmaceuticals Announce Definitive Merger Agreement

[ Thu, Mar 31st 2011 ]: Market Wire

Interim Phase 2 Data Showed Rapid Viral Response .. Telaprevir, Pegylated-Interferon and Ribavirin A

[ Thu, Mar 31st 2011 ]: Market Wire

SuperGen PIM Kinase Presentations at AACR

[ Thu, Mar 31st 2011 ]: Market Wire

SuperGen to Webcast 5th Annual Investor & Analyst Day on April 12, 2011

[ Thu, Mar 31st 2011 ]: Market Wire

A.P. Pharma Announces Transfer to OTCQB

[ Thu, Mar 31st 2011 ]: Market Wire

Inhibitex Reports Positive Safety and Antiviral D .. hase 1b Study of HCV Nucleotide Inhibitor INX-189

[ Thu, Mar 31st 2011 ]: Market Wire

Inhibitex Announces Data Presentation at the 46th .. ean Association for the Study of the Liver (EASL)

[ Thu, Mar 31st 2011 ]: Market Wire

The New England Journal of Medicine Publishes Stu .. ational Medicine VICTRELISa" (boceprevir) in Comb

Wed, March 30, 2011

[ Wed, Mar 30th 2011 ]: Market Wire

CIGNA betritt Privatkundensegment mit neuer Krankenversicherung CIGNA Global Health Options

[ Wed, Mar 30th 2011 ]: Market Wire

CIGNA entra nel mercato sanitario globale per le persone lanciando CIGNA Global Health Options

[ Wed, Mar 30th 2011 ]: Market Wire

CIGNA entra no mercado de atendimento m©dico individual; lanamento do CIGNA Global Health Options

[ Wed, Mar 30th 2011 ]: Market Wire

Antrim Energy Inc. Announces the Filing of Its National Instrument 51-101 Reports

[ Wed, Mar 30th 2011 ]: Market Wire

Bernstein Liebhard LLP Announces Investigation of Offer for Cephalon, Inc.

[ Wed, Mar 30th 2011 ]: Market Wire

Equity Research on Mylan Inc. and Watson Pharmace .. Makers Benefit From Expiring Rights and Expanding

[ Wed, Mar 30th 2011 ]: Market Wire

Yale and Gilead Sciences Announce Cancer Research Collaboration

[ Wed, Mar 30th 2011 ]: Market Wire

Curis Announces Presentations at 102nd American A .. sociation for Cancer Research Annual Meeting 2011

[ Wed, Mar 30th 2011 ]: Market Wire

Medivation and Astellas Announce Initiation of Ph .. ng MDV3100 With Bicalutamide in Advanced Prostate

[ Wed, Mar 30th 2011 ]: Market Wire

BioSante Pharmaceuticals Completes Enrollment in Both Pivotal LibiGel® Phase III Efficacy Trials

[ Wed, Mar 30th 2011 ]: Market Wire

Derma Sciences Reports Fourth Quarter Results; Sa .. oducts up 59% over Prior Year; Total Net Sales Ne

[ Wed, Mar 30th 2011 ]: Market Wire

Dr. Reddya?s Announces Completion of the Acquisit .. cillin Facility and Products from GlaxoSmithKline

[ Wed, Mar 30th 2011 ]: Market Wire

Columbia Laboratories' Provides Update on PREGNANT Study Publication

Tue, March 29, 2011

[ Tue, Mar 29th 2011 ]: Market Wire

Antrim Energy Inc. Reports 2010 Results and Reserves

[ Tue, Mar 29th 2011 ]: Market Wire

Covidien plc informar os resultados do segundo trimestre no dia 21 de abril de 2011

[ Tue, Mar 29th 2011 ]: Market Wire

Mesa Uranium Changes Name to Mesa Exploration

30 a.m. Eastern Time Monday, April 11 to Discuss Phase 3 Trial Results for Dimebon in Huntington Disease

//health-fitness.news-articles.net/content/2011/ .. l-results-for-dimebon-in-huntington-disease.html

Published in Health and Fitness on Friday, April 8th 2011 at 14:05 GMT by Market Wire
^{🞛 This publication is a summary or evaluation of another publication}

SAN FRANCISCO, CA--(Marketwire - April 8, 2011) - Medivation, Inc. (NASDAQ: [ MDVN ]) today announced that it will hold a teleconference and webcast at 8:30 a.m. Eastern Time, Monday, April 11, to discuss the HORIZON Phase 3 trial results for dimebon (latrepirdine) in patients with Huntington disease. A press release will be issued at 7:30 a.m. Eastern Time Monday prior to this call.

Teleconference/Webcast Details

To participate in the live call on Monday, April 11, at 8:30 a.m. Eastern Time (5:30 a.m. Pacific Time), please dial 866-582-8907 for domestic callers and +1-678-825-8232 for international callers. In addition, the live conference call is being webcast and can be accessed on the "Events and Presentations" page of the "Investor Relations" section of the Company's website at [ www.medivation.com ]. A replay also will be available for 30 days following the live call.

About Medivation
Medivation, Inc. is a biopharmaceutical company focused on the rapid development of novel small molecule drugs to treat serious diseases for which there are limited treatment options. Medivation aims to transform the treatment of these diseases and offer hope to critically ill patients and their caregivers. Together with its corporate partners Astellas and Pfizer, Medivation currently has investigational drugs in Phase 3 development to treat advanced prostate cancer, mild-to-moderate Alzheimer's disease and Huntington disease. For more information, please visit us at [ www.medivation.com ].

Publication Contributing Sources

Market Wire is a Trusted Source

Market Wire